Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 207 entries
Sorted by: Best Match Show Resources per page
Fast molecular outflow from a dusty star-forming galaxy in the early Universe.

Science (New York, N.Y.)

Spilker JS, Aravena M, Béthermin M, Chapman SC, Chen CC, Cunningham DJM, De Breuck C, Dong C, Gonzalez AH, Hayward CC, Hezaveh YD, Litke KC, Ma J, Malkan M, Marrone DP, Miller TB, Morningstar WR, Narayanan D, Phadke KA, Sreevani J, Stark AA, Vieira JD, Weiß A.
PMID: 30190403
Science. 2018 Sep 07;361(6406):1016-1019. doi: 10.1126/science.aap8900.

Galaxies grow inefficiently, with only a small percentage of the available gas converted into stars each free-fall time. Feedback processes, such as outflowing winds driven by radiation pressure, supernovae, or supermassive black hole accretion, can act to halt star...

Cite
Spilker JS, Aravena M, Béthermin M, et al. Fast molecular outflow from a dusty star-forming galaxy in the early Universe. Science. 2018;361(6406):1016-1019doi: 10.1126/science.aap8900.
Spilker, J. S., Aravena, M., Béthermin, M., Chapman, S. C., Chen, C. C., Cunningham, D. J. M., De Breuck, C., Dong, C., Gonzalez, A. H., Hayward, C. C., Hezaveh, Y. D., Litke, K. C., Ma, J., Malkan, M., Marrone, D. P., Miller, T. B., Morningstar, W. R., Narayanan, D., Phadke, K. A., Sreevani, J., Stark, A. A., Vieira, J. D., & Weiß, A. (2018). Fast molecular outflow from a dusty star-forming galaxy in the early Universe. Science (New York, N.Y.), 361(6406), 1016-1019. https://doi.org/10.1126/science.aap8900
Spilker, J S, et al. "Fast molecular outflow from a dusty star-forming galaxy in the early Universe." Science (New York, N.Y.) vol. 361,6406 (2018): 1016-1019. doi: https://doi.org/10.1126/science.aap8900
Spilker JS, Aravena M, Béthermin M, Chapman SC, Chen CC, Cunningham DJM, De Breuck C, Dong C, Gonzalez AH, Hayward CC, Hezaveh YD, Litke KC, Ma J, Malkan M, Marrone DP, Miller TB, Morningstar WR, Narayanan D, Phadke KA, Sreevani J, Stark AA, Vieira JD, Weiß A. Fast molecular outflow from a dusty star-forming galaxy in the early Universe. Science. 2018 Sep 07;361(6406):1016-1019. doi: 10.1126/science.aap8900. PMID: 30190403.
Copy Download .nbib Format: NLM
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC).

Patient preference and adherence

Valery PC, Bernardes CM, Stuart KA, Hartel GF, McPhail SM, Skoien R, Rahman T, Clark PJ, Horsfall LU, Hayward KL, Gupta R, Powell EE.
PMID: 32256051
Patient Prefer Adherence. 2020 Mar 18;14:599-611. doi: 10.2147/PPA.S236818. eCollection 2020.

BACKGROUND: We report the development and psychometric testing of a Supportive Needs Assessment tool for Cirrhosis (SNAC).METHODS: The 50-item SNAC was administered to patients (n=465) diagnosed with cirrhosis recruited from five metropolitan hospitals in Queensland, Australia. Items were assessed...

Cite
Valery PC, Bernardes CM, Stuart KA, et al. Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Prefer Adherence. 2020;14:599-611doi: 10.2147/PPA.S236818.
Valery, P. C., Bernardes, C. M., Stuart, K. A., Hartel, G. F., McPhail, S. M., Skoien, R., Rahman, T., Clark, P. J., Horsfall, L. U., Hayward, K. L., Gupta, R., & Powell, E. E. (2020). Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient preference and adherence, 14599-611. https://doi.org/10.2147/PPA.S236818
Valery, Patricia C, et al. "Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)." Patient preference and adherence vol. 14 (2020): 599-611. doi: https://doi.org/10.2147/PPA.S236818
Valery PC, Bernardes CM, Stuart KA, Hartel GF, McPhail SM, Skoien R, Rahman T, Clark PJ, Horsfall LU, Hayward KL, Gupta R, Powell EE. Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Prefer Adherence. 2020 Mar 18;14:599-611. doi: 10.2147/PPA.S236818. eCollection 2020. PMID: 32256051; PMCID: PMC7094148.
Copy Download .nbib Format: NLM
Using Eye Movements to Understand how Security Screeners Search for Threats in X-Ray Baggage.

Vision (Basel, Switzerland)

Donnelly N, Muhl-Richardson A, Godwin HJ, Cave KR.
PMID: 31735825
Vision (Basel). 2019 Jun 04;3(2). doi: 10.3390/vision3020024.

There has been an increasing drive to understand failures in searches for weapons and explosives in X-ray baggage screening. Tracking eye movements during the search has produced new insights into the guidance of attention during the search, and the...

Cite
Donnelly N, Muhl-Richardson A, Godwin HJ, et al. Using Eye Movements to Understand how Security Screeners Search for Threats in X-Ray Baggage. Vision (Basel). 2019;3(2)doi: 10.3390/vision3020024.
Donnelly, N., Muhl-Richardson, A., Godwin, H. J., & Cave, K. R. (2019). Using Eye Movements to Understand how Security Screeners Search for Threats in X-Ray Baggage. Vision (Basel, Switzerland), 3(2), . https://doi.org/10.3390/vision3020024
Donnelly, Nick, et al. "Using Eye Movements to Understand how Security Screeners Search for Threats in X-Ray Baggage." Vision (Basel, Switzerland) vol. 3,2 (2019). doi: https://doi.org/10.3390/vision3020024
Donnelly N, Muhl-Richardson A, Godwin HJ, Cave KR. Using Eye Movements to Understand how Security Screeners Search for Threats in X-Ray Baggage. Vision (Basel). 2019 Jun 04;3(2). doi: 10.3390/vision3020024. PMID: 31735825; PMCID: PMC6802782.
Copy Download .nbib Format: NLM
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics.

Hepatology communications

Elangovan H, Rajagopaul S, Williams SM, McKillen B, Britton L, McPhail SM, Horsfall LU, Valery PC, Hayward KL, Powell EE.
PMID: 32258947
Hepatol Commun. 2020 Feb 20;4(4):518-526. doi: 10.1002/hep4.1486. eCollection 2020 Apr.

Primary care physicians (PCPs) have the primary role in the diagnosis and management of nonalcoholic fatty liver disease (NAFLD), and in selecting patients for referral to a hepatologist for further evaluation. This study aimed to characterize PCP referrals for...

Cite
Elangovan H, Rajagopaul S, Williams SM, et al. Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. Hepatol Commun. 2020;4(4):518-526doi: 10.1002/hep4.1486.
Elangovan, H., Rajagopaul, S., Williams, S. M., McKillen, B., Britton, L., McPhail, S. M., Horsfall, L. U., Valery, P. C., Hayward, K. L., & Powell, E. E. (2020). Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. Hepatology communications, 4(4), 518-526. https://doi.org/10.1002/hep4.1486
Elangovan, Harendran, et al. "Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics." Hepatology communications vol. 4,4 (2020): 518-526. doi: https://doi.org/10.1002/hep4.1486
Elangovan H, Rajagopaul S, Williams SM, McKillen B, Britton L, McPhail SM, Horsfall LU, Valery PC, Hayward KL, Powell EE. Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. Hepatol Commun. 2020 Feb 20;4(4):518-526. doi: 10.1002/hep4.1486. eCollection 2020 Apr. PMID: 32258947; PMCID: PMC7109341.
Copy Download .nbib Format: NLM
Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care.

Internal medicine journal

Hayward KL, McKillen BJ, Horsfall LU, McIvor C, Liew K, Sexton J, Johnson AL, Irvine KM, Valery PC, McPhail SM, Britton LJ, Rosenberg W, Weate I, Williams S, Powell EE.
PMID: 34139066
Intern Med J. 2021 Jun 17; doi: 10.1111/imj.15422. Epub 2021 Jun 17.

BACKGROUND: The optimal strategy to support primary care practitioners (PCPs) to assess fibrosis severity in nonalcoholic fatty liver disease (NAFLD) and thereby make appropriate management decisions remains unclear.AIMS: We aimed to examine the feasibility of using a 2-step pathway...

Cite
Hayward KL, McKillen BJ, Horsfall LU, et al. Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care. Intern Med J. 2021;doi: 10.1111/imj.15422.
Hayward, K. L., McKillen, B. J., Horsfall, L. U., McIvor, C., Liew, K., Sexton, J., Johnson, A. L., Irvine, K. M., Valery, P. C., McPhail, S. M., Britton, L. J., Rosenberg, W., Weate, I., Williams, S., & Powell, E. E. (2021). Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care. Internal medicine journal, . https://doi.org/10.1111/imj.15422
Hayward, Kelly L, et al. "Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care." Internal medicine journal vol. (2021). doi: https://doi.org/10.1111/imj.15422
Hayward KL, McKillen BJ, Horsfall LU, McIvor C, Liew K, Sexton J, Johnson AL, Irvine KM, Valery PC, McPhail SM, Britton LJ, Rosenberg W, Weate I, Williams S, Powell EE. Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care. Intern Med J. 2021 Jun 17; doi: 10.1111/imj.15422. Epub 2021 Jun 17. PMID: 34139066.
Copy Download .nbib Format: NLM
Universities and nursing education.

Journal of advanced nursing

Hayward J.
PMID: 6922880
J Adv Nurs. 1982 Jul;7(4):371-7. doi: 10.1111/j.1365-2648.1982.tb00252.x.

Trends reflected by Department of Health and Social Security statistics on the nursing workforce are examined and the ratios between grades discussed. Recruitment into nursing degree courses in the UK is considered in relation to overall recruitment into nursing....

Cite
Hayward J. Universities and nursing education. J Adv Nurs. 1982;7(4):371-7doi: 10.1111/j.1365-2648.1982.tb00252.x.
Hayward, J. (1982). Universities and nursing education. Journal of advanced nursing, 7(4), 371-7. https://doi.org/10.1111/j.1365-2648.1982.tb00252.x
Hayward, J. "Universities and nursing education." Journal of advanced nursing vol. 7,4 (1982): 371-7. doi: https://doi.org/10.1111/j.1365-2648.1982.tb00252.x
Hayward J. Universities and nursing education. J Adv Nurs. 1982 Jul;7(4):371-7. doi: 10.1111/j.1365-2648.1982.tb00252.x. PMID: 6922880.
Copy Download .nbib Format: NLM
Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors.

Journal of evolutionary biology

Barnard KN, Wasik BR, Alford BK, Hayward JJ, Weichert WS, Voorhees IEH, Holmes EC, Parrish CR.
PMID: 34114711
J Evol Biol. 2021 Jun 11; doi: 10.1111/jeb.13890. Epub 2021 Jun 11.

Viruses are often cultured in cell lines for research and vaccine development, and those often differ from the natural hosts or tissues. Cell lines can also differ in the presence of virus receptors, such as the sialic acid (Sia)...

Cite
Barnard KN, Wasik BR, Alford BK, et al. Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. J Evol Biol. 2021;doi: 10.1111/jeb.13890.
Barnard, K. N., Wasik, B. R., Alford, B. K., Hayward, J. J., Weichert, W. S., Voorhees, I. E. H., Holmes, E. C., & Parrish, C. R. (2021). Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. Journal of evolutionary biology, . https://doi.org/10.1111/jeb.13890
Barnard, Karen N, et al. "Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors." Journal of evolutionary biology vol. (2021). doi: https://doi.org/10.1111/jeb.13890
Barnard KN, Wasik BR, Alford BK, Hayward JJ, Weichert WS, Voorhees IEH, Holmes EC, Parrish CR. Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. J Evol Biol. 2021 Jun 11; doi: 10.1111/jeb.13890. Epub 2021 Jun 11. PMID: 34114711.
Copy Download .nbib Format: NLM
International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs.

International urogynecology journal

Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV, Mukhtarova N, Mbwele B, Tailor V, Kocjancic E, Trowbridge E, Hayward L.
PMID: 34977950
Int Urogynecol J. 2022 Jan 03; doi: 10.1007/s00192-021-05018-z. Epub 2022 Jan 03.

INTRODUCTION AND HYPOTHESIS: This narrative review describes the existing epidemiologic literature and identifies gaps regarding pelvic organ prolapse (POP) prevalence, incidence, natural history, and current and future service needs.MATERIALS AND METHODS: A PubMed search identified relevant citations published in...

Cite
Brown HW, Hegde A, Huebner M, et al. International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. Int Urogynecol J. 2022;doi: 10.1007/s00192-021-05018-z.
Brown, H. W., Hegde, A., Huebner, M., Neels, H., Barnes, H. C., Marquini, G. V., Mukhtarova, N., Mbwele, B., Tailor, V., Kocjancic, E., Trowbridge, E., & Hayward, L. (2022). International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. International urogynecology journal, . https://doi.org/10.1007/s00192-021-05018-z
Brown, Heidi W, et al. "International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs." International urogynecology journal vol. (2022). doi: https://doi.org/10.1007/s00192-021-05018-z
Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV, Mukhtarova N, Mbwele B, Tailor V, Kocjancic E, Trowbridge E, Hayward L. International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. Int Urogynecol J. 2022 Jan 03; doi: 10.1007/s00192-021-05018-z. Epub 2022 Jan 03. PMID: 34977950.
Copy Download .nbib Format: NLM
Managing medicines in alcohol-associated liver disease: a practical review.

Australian prescriber

Johnson AL, Hayward KL.
PMID: 34211248
Aust Prescr. 2021 Jun;44(3):96-106. doi: 10.18773/austprescr.2021.015. Epub 2021 Jun 01.

People with alcohol-associated liver disease often take medicines to manage complications of liver disease and comorbidities. However, patients may be at increased risk of drug-related harm Assessing the severity of liver disease is fundamental to management, as disease staging...

Cite
Johnson AL, Hayward KL. Managing medicines in alcohol-associated liver disease: a practical review. Aust Prescr. 2021;44(3):96-106doi: 10.18773/austprescr.2021.015.
Johnson, A. L., & Hayward, K. L. (2021). Managing medicines in alcohol-associated liver disease: a practical review. Australian prescriber, 44(3), 96-106. https://doi.org/10.18773/austprescr.2021.015
Johnson, Amy L, and Hayward, Kelly L. "Managing medicines in alcohol-associated liver disease: a practical review." Australian prescriber vol. 44,3 (2021): 96-106. doi: https://doi.org/10.18773/austprescr.2021.015
Johnson AL, Hayward KL. Managing medicines in alcohol-associated liver disease: a practical review. Aust Prescr. 2021 Jun;44(3):96-106. doi: 10.18773/austprescr.2021.015. Epub 2021 Jun 01. PMID: 34211248; PMCID: PMC8236868.
Copy Download .nbib Format: NLM
Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.

Obstetrics and gynecology

Nazareth S, Hayward L, Simmons E, Snir M, Hatchell KE, Rojahn S, Slotnick RN, Nussbaum RL.
PMID: 34735417
Obstet Gynecol. 2021 Dec 01;138(6):860-870. doi: 10.1097/AOG.0000000000004596.

OBJECTIVE: To examine user uptake and experience with a clinical chatbot that automates hereditary cancer risk triage by collecting personal and family cancer history in routine women's health care settings.METHODS: We conducted a multicenter, retrospective observational study of patients...

Cite
Nazareth S, Hayward L, Simmons E, et al. Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits. Obstet Gynecol. 2021;138(6):860-870doi: 10.1097/AOG.0000000000004596.
Nazareth, S., Hayward, L., Simmons, E., Snir, M., Hatchell, K. E., Rojahn, S., Slotnick, R. N., & Nussbaum, R. L. (2021). Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits. Obstetrics and gynecology, 138(6), 860-870. https://doi.org/10.1097/AOG.0000000000004596
Nazareth, Shivani, et al. "Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits." Obstetrics and gynecology vol. 138,6 (2021): 860-870. doi: https://doi.org/10.1097/AOG.0000000000004596
Nazareth S, Hayward L, Simmons E, Snir M, Hatchell KE, Rojahn S, Slotnick RN, Nussbaum RL. Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits. Obstet Gynecol. 2021 Dec 01;138(6):860-870. doi: 10.1097/AOG.0000000000004596. PMID: 34735417; PMCID: PMC8594498.
Copy Download .nbib Format: NLM
Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors.

Journal of evolutionary biology

Barnard KN, Wasik BR, Alford BK, Hayward JJ, Weichert WS, Voorhees IEH, Holmes EC, Parrish CR.
PMID: 34114711
J Evol Biol. 2021 Dec;34(12):1878-1900. doi: 10.1111/jeb.13890. Epub 2021 Jun 27.

Viruses are often cultured in cell lines for research and vaccine development, and those often differ from the natural hosts or tissues. Cell lines can also differ in the presence of virus receptors, such as the sialic acid (Sia)...

Cite
Barnard KN, Wasik BR, Alford BK, et al. Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. J Evol Biol. 2021;34(12):1878-1900doi: 10.1111/jeb.13890.
Barnard, K. N., Wasik, B. R., Alford, B. K., Hayward, J. J., Weichert, W. S., Voorhees, I. E. H., Holmes, E. C., & Parrish, C. R. (2021). Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. Journal of evolutionary biology, 34(12), 1878-1900. https://doi.org/10.1111/jeb.13890
Barnard, Karen N, et al. "Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors." Journal of evolutionary biology vol. 34,12 (2021): 1878-1900. doi: https://doi.org/10.1111/jeb.13890
Barnard KN, Wasik BR, Alford BK, Hayward JJ, Weichert WS, Voorhees IEH, Holmes EC, Parrish CR. Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors. J Evol Biol. 2021 Dec;34(12):1878-1900. doi: 10.1111/jeb.13890. Epub 2021 Jun 27. PMID: 34114711.
Copy Download .nbib Format: NLM
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.

The Journal of infection

Boshier FAT, Venturini C, Stirrup O, Guerra-Assunção JA, Alcolea-Medina A, Becket AH, Byott M, Charalampous T, Filipe ADS, Frampton D, Glaysher S, Khan T, Kulasegara-Shylini R, Kele B, Monahan IM, Mollett G, Parker M, Pelosi E, Randell P, Roy S, Taylor JF, Weller SJ, Wilson-Davies E, Wade P, Williams R, Copas AJ, Cutino-Moguel T, Freemantle N, Hayward AC, Holmes A, Hughes J, Mahungu TW, Nebbia G, Nastouli E, Partridge DG, Pope CF, Price JR, Robson SC, Saeed K, Shin GY, de Silva TI, Snell LB, Thomson EC, Witney AA, Breuer J.
PMID: 34610391
J Infect. 2021 Dec;83(6):693-700. doi: 10.1016/j.jinf.2021.09.022. Epub 2021 Oct 02.

OBJECTIVES: Recently emerging SARS-CoV-2 variants have been associated with an increased rate of transmission within the community. We sought to determine whether this also resulted in increased transmission within hospitals.METHODS: We collected viral sequences and epidemiological data of patients...

Cite
Boshier FAT, Venturini C, Stirrup O, et al. The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study. J Infect. 2021;83(6):693-700doi: 10.1016/j.jinf.2021.09.022.
Boshier, F. A. T., Venturini, C., Stirrup, O., Guerra-Assunção, J. A., Alcolea-Medina, A., Becket, A. H., Byott, M., Charalampous, T., Filipe, A. D. S., Frampton, D., Glaysher, S., Khan, T., Kulasegara-Shylini, R., Kele, B., Monahan, I. M., Mollett, G., Parker, M., Pelosi, E., Randell, P., Roy, S., Taylor, J. F., Weller, S. J., Wilson-Davies, E., Wade, P., Williams, R., Copas, A. J., Cutino-Moguel, T., Freemantle, N., Hayward, A. C., Holmes, A., Hughes, J., Mahungu, T. W., Nebbia, G., Nastouli, E., Partridge, D. G., Pope, C. F., Price, J. R., Robson, S. C., Saeed, K., Shin, G. Y., de Silva, T. I., Snell, L. B., Thomson, E. C., Witney, A. A., Breuer, J. (2021). The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study. The Journal of infection, 83(6), 693-700. https://doi.org/10.1016/j.jinf.2021.09.022
Boshier, Florencia A T, et al. "The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study." The Journal of infection vol. 83,6 (2021): 693-700. doi: https://doi.org/10.1016/j.jinf.2021.09.022
Boshier FAT, Venturini C, Stirrup O, Guerra-Assunção JA, Alcolea-Medina A, Becket AH, Byott M, Charalampous T, Filipe ADS, Frampton D, Glaysher S, Khan T, Kulasegara-Shylini R, Kele B, Monahan IM, Mollett G, Parker M, Pelosi E, Randell P, Roy S, Taylor JF, Weller SJ, Wilson-Davies E, Wade P, Williams R, Copas AJ, Cutino-Moguel T, Freemantle N, Hayward AC, Holmes A, Hughes J, Mahungu TW, Nebbia G, Nastouli E, Partridge DG, Pope CF, Price JR, Robson SC, Saeed K, Shin GY, de Silva TI, Snell LB, Thomson EC, Witney AA, Breuer J. The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study. J Infect. 2021 Dec;83(6):693-700. doi: 10.1016/j.jinf.2021.09.022. Epub 2021 Oct 02. PMID: 34610391; PMCID: PMC8487101.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 207 entries